After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback